Navigation Links
ResMed Inc. to Present at Upcoming Conferences in June
Date:5/27/2009

SAN DIEGO, May 27 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that it will be presenting at three upcoming conferences. David Pendarvis, SVP Organization Development and General Counsel will present at the William Blair Growth Stock Conference at the Four Seasons in Chicago on June 10, 2009 at 9:20 a.m. US Central Time. Kieran Gallahue, President and CEO will present at the Jefferies Third Annual Healthcare Conference at the Mandarin Oriental in New York City on June 18, 2009 at 9:30 a.m. US Eastern Time. David Pendarvis, SVP Organization Development and General Counsel will present at the Wachovia/Wells Fargo Annual Mid-Year Equity Conference at the Intercontinental Boston Hotel in Boston on June 23, 2009 at 4:00 p.m. US Eastern Time.

The Company's presentations will be webcast. To access the live webcast or the archived webcast of the presentation, please log onto the Company's website at http://investor.resmed.com. Further information can be obtained by contacting Constance Bienfait at ResMed Inc., San Diego, at +1(858) 836-5971 or by visiting the Company's multilingual Web site at www.resmed.com.

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.


'/>"/>
SOURCE ResMed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ResMed Inc. to Present at Upcoming Healthcare Conferences in May
2. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results
3. ResMed Inc Announces Record Financial Results for the Quarter and Six Months Ended December 31, 2008
4. ResMed to Webcast Second Quarter 2009 Earnings Conference Call
5. ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008
6. ResMed to Webcast First Quarter 2009 Earnings Conference Call
7. ResMed to Webcast Third Quarter 2008 Earnings Conference Call
8. RESMED to Webcast Second Quarter 2008 Earnings Conference Call
9. ResMed to Webcast First Quarter 2008 Earnings Conference Call
10. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
11. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: